Home > Journals > Medicine > European Journal of Dermatology > Full text
 
      Advanced search    Shopping cart    French version 
 
Latest books
Catalogue/Search
Collections
All journals
Medicine
European Journal of Dermatology
- Current issue
- Archives
- Subscribe
- Order an issue
- More information
Biology and research
Public health
Agronomy and biotech.
My account
Forgotten password?
Online account   activation
Subscribe
Licences IP
- Instructions for use
- Estimate request form
- Licence agreement
Order an issue
Pay-per-view articles
Newsletters
How can I publish?
Journals
Books
Help for advertisers
Foreign rights
Book sales agents



 

Texte intégral de l'article
 
  Printable version
  Version PDF

Allergic contact dermatitis


European Journal of Dermatology. Volume 14, Number 5, 284-95, September-October 2004, Review article


Summary  

Author(s) : Pierre SAINT-MEZARD, Aurore ROSIERES, Maya KRASTEVA, Frédéric BERARD, Bertrand DUBOIS, Dominique KAISERLIAN, Jean-François NICOLAS , INSERM U 503, IFR 128 Bioscience Lyon-Gerland, 21, avenue Tony Garnier 69007 Lyon, INSERM U 404, IFR 128 Bioscience Lyon-Gerland, 21, avenue Tony Garnier 69007 Lyon, Clinical Immunology and Allergy Unit, CH Lyon-Sud, 69495 Pierre-Benite Cedex, France., J.F. Nicolas, Fax: (+33) 478 861 528. E-mail: jean-francois.nicolas@chu-lyon.fr.

Summary : Contact dermatitis is an inflammatory skin condition induced by exposure to an environmental agent. Eczema and dermatitis are used synonymously to denote a polymorphous pattern of skin inflammation characterized at least in its acute phase by erythema, vesiculation and pruritus. Substances responsible for contact dermatitis after single or multiple exposures are non protein chemicals, i.e. haptens, that induce skin inflammation through activation of innate skin immunity (irritant contact dermatitis) or both innate and acquired specific immunity (allergic contact dermatitis). The present review will focus on allergic contact dermatitis, a delayed-type hypersensitivity reaction, which is mediated by hapten-specific T cells. Recent advances in the pathophysiology of ACD have shown that the occurrence of ACD, as well as its magnitude and duration, is controlled by the opposite functions of CD8 effector T cells and CD4 regulatory T cells. From these studies ACD can be considered as a breakdown of cutaneous immune tolerance to haptens.

Keywords : haptens, CD8 T cells, CTL, CD4 regulatory T cells, tolerance, contact sensitivity, contact dermatitis

Pictures

Figure 1 Pathophysiology of CHSSensitization step: Haptens penetrate the stratum corneum. Hapten loading by skin dendritic cells (step 1) parallels activation and migration of DC through the afferent lymphatic vessels to the draining lymph nodes (step 2). Migrating DC are located in the para-cortical area of the draining LN where they can present haptenated peptides on MHC class I and II molecules to CD8+ and CD4+ T cells, respectively (step 3). Specific T cells precursors expand clonally in the draining LN and diffuse to the bloodstream through the efferent lymphatic vessels and the thoracic duct (step 4). During this process they acquire skin-specific homing antigens (CLA and CCR4) and become memory T cells. Primed T cells preferentially diffuse in the skin after transendothelial migration. At the end of the sensitization step everything is ready for the development of a CS reaction upon challenge with the relevant hapten.Elicitation phase: When the hapten is painted for a second (and subsequent) time, it diffuses through the epidermis and could be loaded by LC or other skin cells expressing MHC molecules, such as keratinocytes and dermal dendritic cells, which are then able to activate trafficking specific T cells (step 5). CD8+ cytotoxic T cell activation initiates the inflammatory process through keratinocyte apoptosis and cytokine/chemokine production (step 6). This is responsible for the recruitment of leukocytes (including regulatory T cells) from the blood to the skin leading to the development of skin lesions (step 7).

Figure 2 Clinical aspect of ACD.

Figure 3 Histopathologic features of ACD.


 

About us - Contact us - Conditions of use - Secure payment
Latest news - Conferences
Copyright © 2007 John Libbey Eurotext - All rights reserved
[ Legal information - Powered by Dolomède ]